5 UK shares for a passive income

These five dividend shares have great potential as passive income investments, according to this Fool, who’d buy all of them today.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

I believe buying UK shares is one of the most straightforward strategies to generate a passive income. 

With that in mind, here are five investments I would buy for my portfolio today with this goal in mind. 

Passive income investments

The first company on my list is pharmaceutical giant GlaxoSmithKline. At the time of writing, this stock yields 6%. As healthcare is a defensive and growing industry, I think this dividend is sustainable, which is why I would buy it as a foundation holding in my passive income portfolio. 

Of course, like all income investments, if Glaxo suffers a sudden drop in income, the company may have to cut the distribution. This is a risk that comes with all dividend stocks. 

The second stock I would buy for a passive income is British American Tobacco. Ethical considerations aside, this company has a solid track record of dividend growth. The shares currently support a dividend yield of 8%, and the stock is trading at a forward P/E of 8.1. Despite these attractive qualities, I’m well aware tobacco sales are in terminal decline. This is the biggest challenge the group currently faces. 

Profit growth

Asset manager Rathbone Brothers should benefit from the UK’s ageing population and increased savings pot over the next few years, in my opinion. These tailwinds should drive customers towards the business, leading to increased profit growth and larger profit margins. More significant margins will support the company’s dividend yield of 4.3%.

That being said, regulatory headwinds and higher costs could impact other margins, limiting the company’s ability to return cash to investors. That’s something I plan to keep an eye on going forward. Nevertheless, despite these risks, I would buy the business for my portfolio. 

HICL Infrastructure owns a portfolio of infrastructure assets across the UK. Infrastructure assets can be the perfect income investments because they can generate a steady income stream for decades. The stock currently supports a dividend yield of 4.8%, and the company has a track record of above-inflation dividend growth.

However, the company uses a lot of debt to fund its assets. Therefore, a primary risk of investing in this business is the potential for interest rate increases, making it harder for the organisation to sustain its debt. In the worst-case scenario, HICL could have to eliminate its dividend to meet creditor obligations. Even after taking this risk into account, I would still buy the stock. 

Hedge fund income 

The final company I’d buy is Man Group. With a projected dividend yield of 4.6%, this publicly traded hedge fund is a dividend darling. It can also generate profits in any market environment with its computerised trading strategies. The biggest challenge facing the group is maintaining customer loyalty in the viciously competitive hedge fund sector. If its performance is not maintained, customers could move elsewhere, putting profits and the dividend under pressure. 

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Rupert Hargreaves owns no share mentioned. The Motley Fool UK has recommended GlaxoSmithKline and Rathbone Brothers. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »